Handelsavisen
prelaunch
Companies Healthcare AMSL.CM
AM
AMSL.CM Healthcare Facilities & Services

Asiri Surgical Hospital PLC

$24,60
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
15,9 %
ROE
2,3 %
Net margin
9,0 %
Debt / equity
0,50
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Asiri Surgical Hospital PLC operates in the healthcare facilities and services industry, providing surgical and related medical services to patients in Sri Lanka.

Business. Asiri Surgical Hospital PLC (AMSL.CM) operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Sri Lanka and is listed on the Colombo Stock Exchange under the ticker AMSL.CM. Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
2,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AMSL.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AMSL.CM. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Asiri Surgical Hospital PLC (AMSL.CM) operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Sri Lanka and is listed on the Colombo Stock Exchange under the ticker AMSL.CM. Specific details regarding operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    Asiri Surgical Hospital PLC maintains a debt-to-equity ratio of 0.5, indicating a balanced capital structure with moderate leverage. The company's liquidity position is characterized as medium, with a current ratio of 1.5, suggesting it can cover short-term obligations but with limited buffer. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.

    Profitability metrics show a return on equity (ROE) of 2.26% and a return on assets (ROA) of 1.08%, both below the industry median for healthcare facilities and services. These figures suggest the company is underperforming in terms of capital efficiency and asset utilization.

    The company's revenue is concentrated in a single geographic market, Sri Lanka, with no disclosed international operations. This geographic concentration increases exposure to local economic and regulatory risks. No segment-specific revenue breakdown is available, limiting visibility into the performance of different service lines.

    Looking ahead, the company's revenue is expected to grow, though the exact rate is not disclosed. Historical revenue of LKR 1.7 billion provides a baseline for future performance. The company's free cash flow of LKR 242.99 million indicates some capacity for reinvestment or shareholder returns, though capital expenditures of LKR 39.81 million suggest ongoing investment in infrastructure.

    The company's risk profile is marked by medium liquidity risk and low dilution potential. The negative net cash position after debt is a key flag, but the absence of recent dilutive events and a stable share count suggest no immediate pressure on equity. No recent filings or transcripts are available to provide additional context on strategic or operational developments.

    Key takeaways
    • Asiri Surgical Hospital PLC maintains a balanced capital structure with a debt-to-equity ratio of 0.5.
    • The company's ROE and ROA are below industry medians, indicating suboptimal capital and asset efficiency.
    • Revenue is concentrated in Sri Lanka, increasing exposure to local economic and regulatory risks.
    • Free cash flow of LKR 242.99 million provides some flexibility for reinvestment or shareholder returns.
    • The company's liquidity position is medium, with a current ratio of 1.5 and a negative net cash position after debt.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Net income surged 209.7% year-over-year to LKR 822.9 million, demonstrating strong recent profitability recovery.

    Free cash flow increased 114.1% year-over-year to LKR 857.6 million, highlighting improved cash generation capabilities.

    Revenue grew 7.5% year-over-year to LKR 7.72 billion, showing consistent top-line expansion in the latest period.

    Debt-to-equity ratio of 0.5 is below the cohort median of 0.32, suggesting a conservative leverage position.

    BEAR CASE · 4

    Cash conversion ratio of -1.29 ranks in the bottom quartile, signaling poor cash flow quality relative to earnings.

    The company faces high credit risk, posing significant potential challenges to financial stability and borrowing costs.

    Net income CAGR of -8.7% over four years reveals long-term earnings volatility despite recent growth.

    Medium liquidity risk flags potential difficulties in meeting short-term financial obligations or operational needs.

    In focus — financials by report

    Annual
    ANNUALFiled 2024-05-31
    FY 2024 · Full-year highlights

    Revenue LKR 6.62B, +17,5% YoY; Operating income −51,5% YoY.

    RevenueLKR 6.62B+17,5 % YoY
    Operating incomeLKR 484.9M−51,5 % YoY
    Net incomeLKR 31.6M−94,3 % YoY
    Free cash flowLKR 387.8M+102,2 % YoY
    EPS
    Operating cash flowLKR 245.8M−56,9 % YoY
    Financials
    Income statement
    RevenueLKR 6.62B
    Gross profitLKR 2.67B
    Operating incomeLKR 484.9M
    Net incomeLKR 31.6M
    Margins
    Gross margin40.3%
    Operating margin7.3%
    Net margin0.5%
    FCF margin5.9%
    Balance sheet
    Total assetsLKR 13.05B
    Total liabilitiesLKR 6.85B
    Total equityLKR 6.19B
    Cash & equivalentsLKR 461.1M
    Long-term debtLKR 3.27B
    Cash flow
    Operating cash flowLKR 245.8M
    CapEx-LKR 146.9M
    Free cash flowLKR 387.8M
    SBC
    P&L flow · revenue → net income
    Revenue LKR 1.70BOperating costs LKR 1.43BNet income LKR 152.9M
    Highlights
    • Revenue LKR 6.62B, +17,5% YoY
    • Operating income −51,5% YoY
    • Net income −94,3% YoY
    • Free cash flow +102,2% YoY
    • Net margin 0.5%

    Valuation FY

    Market price
    $24,60
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $6.77B
    Net cash
    -$2.67B
    Current ratio
    1.5
    Debt / equity
    0.5
    ROA
    1.1%
    ROE
    2.3%
    Cash conversion
    -129.0%
    CapEx / revenue
    -2.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin15,9 %Above P75
    Net Margin9,0 %Above median
    ROE2,3 %Below median
    Capex / Rev-2,4 %Above P75
    D/E0,50Below median
    Cash Conv-1,29Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Asiri Surgical Hospital PLC Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AMSL.CMCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2024-05-31 16:37 UTCEARNINGSAnnual results — FY 2024 Revenue LKR 6.62B · Net LKR 31.6M
    2023-06-05 09:55 UTCEARNINGSAnnual results — FY 2023 Revenue LKR 5.63B · Net LKR 555.1M
    2022-05-24 17:02 UTCEARNINGSAnnual results — FY 2022 Revenue LKR 5.84B · Net LKR 1.18B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage